Stage Duration / h Clinical features
I 0.5–24 loss of appetite and anorexia (Chapter 10),
nausea and vomiting,
general malaise,
patient appears normal
II 24–48 less severe symptoms,
abnormal blood chemistry with increases in liver enzymes and bilirubin,
deterioration in renal functions but blood urea concentration remains low
given the decrease in liver function
III 72–96 signs of hepatic necrosis,
coagulation defects, jaundice and renal failure,
reappearance of nausea and vomiting,
death due to hepatic failure
IV 4–14 days hepatic and renal functions return to normal if patient survives stage III
Table 12.2Stages of paracetamol poisoning
Laboratory investigations of paracetamol poisoning
Estimating the concentration of paracetamol in plasma is useful for assessing
the probability of patients developing hepatotoxicity. A nomogram (Figure
12.8) is available for paracetamol poisoning but should only be used when
the size of the overdose and the approximate time of ingestion are known.
Blood samples for paracetamol determination should be drawn at least 4 h
postdose to allow for its complete absorption and the serum concentration
to peak. The concentration of paracetamol in plasma can be used as a guide
to patient management. Other tests that may be useful are determining the
X]VeiZg&'/ TOXICOLOGY
W^dad\nd[Y^hZVhZ
Figure 12.8 A nomogram to assess paracetamol
toxicity.
500
300
200
100
50
25
10
4 5 6 7 8 9 10 11 12 13 14 15
Time after ingestion / h
Plasma [paracetamol] / mg dm
-3
Toxicity unlikely
Mild toxicity
Moderate toxicity
Severe toxicity
that may be fatal
X]VeiZg&'/ TOXICOLOGY
(') W^dad\nd[Y^hZVhZ